CJC-1295 No DAC with Ipamorelin is a research-grade peptide blend designed for scientific and laboratory research applications. This combination pairs CJC-1295 No DAC, a growth hormone-releasing hormone (GHRH) analog, with Ipamorelin, a selective growth hormone secretagogue, creating a synergistic peptide formulation frequently investigated in studies involving growth hormone release and endocrine signaling.

Researchers utilize this peptide combination to explore mechanisms related to growth hormone pulsatility, metabolic function, recovery processes, body composition, and cellular signaling pathways. The absence of DAC (Drug Affinity Complex) in CJC-1295 results in a shorter activity profile, making it a valuable tool for research involving natural growth hormone pulse patterns.